GFAP immunoreactivity was also increased in the MCD group and tended to decrease after naringin treatment, although the change did not reach statistical significance ( Figure 9 D).
← all excerpts
Naringin Attenuates Steatosis, Oxidative Stress, Inflammation, and Fibrosis in MASH: Network Pharmacology and In Vivo Study.
1
—
—